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To the Editor: In their interesting review on Randall’s plaque,
Evan et al.1 go through a number of rodent models where
hypercalciuria with/without stones or nephrocalcinosis have
been observed, but do not form Randall’s plaque-like
structures. The list is incomplete, as they themselves pointed
out. In our opinion, the Nuf rat model should be added:2 this
rat has an activating mutation of the calcium-sensing
receptor, which leads to calcifications at various renal levels
and – of particular interest – in papillary ducts in up to 63%
of heterozygous animals. Whether Randall’s plaques exist in
such a model is not known and cannot be ascertained from
published pictures. Calcification interestingly occurs with no
associated hypercalciuria. This model is attractive in relation
to human idiopathic calcium stone disease (idiopathic
calcium nephrolithiasis). Quite recently, Soldati et al.3
showed that an activating polymorphism of the calcium-
sensing receptor is associated with hypercalciuria in idio-
pathic calcium nephrolithiasis, and Terranegra et al.4 have
reported that calcium-sensing receptor SNPs form a
haplotype block associated with idiopathic calcium nephro-
lithiasis and increase the risk of stones by as much as 3.36
times. Looking for the occurrence of Randall’s plaques in the
Nuf rat might therefore be highly rewarding.
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To the Editor: In an excellent review of their recent work,
authors indicate that renal epithelial cells associated with the
interstitial plaques ‘invariably appear normal, as does the
cellular interstitium’.1 However, illustrations in their various
publications show a number of structural abnormalities.
Interstitium is enlarged with abundant collagen. Basement
membrane is thickened and at places multilamellate.
Dispersed in the basement membrane are crystals that often
encircle the renal tubules, which appear necrotic.
Authors found osteopontin in the matrix of interstitial
crystals. In normal human kidneys, osteopontin is localized
primarily to epithelial cells lining the distal nephrons and
ascending limbs of the loop of Henle.2 Interstitial localization
of osteopontin is quite abnormal and is seen only in the
injured kidneys.
Previous studies of the plaque have reported renal
epithelial injury manifested as excessive collagen in the
papillary interstitium, necrosis of the tubular epithelium, and
thickening of the tubular basal lamina.3 Randall himself
concluded that damage to the cells and interstitium preceded
plaque formation.4
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and cell injury’
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We disagree with Professor Khan.1
The interstitial space of idiopathic CaOx stone formers
(ICSF) is not enlarged, and medullary tubular basement
membrane thickness is not increased. Human papillary tip
interstitial volume normally exceeds that of rats (the most
commonly studied kidney).2 Because the method of
fixation (immersion vs perfusion) and patient age influence
medullary tubular basement membrane thickness,3,4 one
cannot call the medullary tubular basement membrane of
our ICSF (mean age¼ 49 years, immersion fixed tissue)
normal or abnormal.
Papillary biopsies of our ICSF do not show cell necrosis.
Haggitt and Pitcock, who Khan refers to, examined kidneys
from 100 randomly selected autopsies. Their Figure 6
legend describes postmortem degeneration, which is not
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